Conestoga Small Cap Fund Investors Class (CCASX)

51.44
Net Asset Value
-0.50%
1 Day
+5.09%
Year-to-Date
Overall Morningstar Rating
Small growth
Style or Category
No Load
Sales Expenses
1.54%
Expense Ratio
Average
Morningstar Risk Rating™
Investment Objective The investment seeks long-term growth of capital. Under normal market circumstances- the fund invests at least 80% of its net assets in equity securities of small-cap companies. Equity securities include American depositary receipts ("ADRs")- convertible securities- foreign and domestic common and preferred stocks- rights and warrants.

Performance

1 month+1.48% 3 years+16.22%
3 months+0.96% 5 years+16.58%
1 year+29.20% Since inception+12.34%
Data through --

Peer Comparisonvs. Small growth

 CCASXCategory
Performance 5-yr return+16.58%+11.88%
Expense ratio1.54%1.27%
Risk 5 year sharpe ratio0.960.87
Net assets$1.8B$1.1B
Average market cap$2.1B$3.4B
Average P/E36.626.7
Portfolio turnover24%24%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyConestoga Capital Advisors
Fund manager & tenureRobert Mitchell / 15 Years
Minimal initial investment$2,500.00
Minimum IRA investment--

Holdings

U.S. stock91.18%
Cash5.99%
International stock2.82%
Fixed income0.00%
Other0.00%
Top 5 Sectors
Portfolio weighting
Business service 19.67%
Healthcare 12.89%
Hardware 12.07%
Industrial materials 10.80%
Energy 8.99%
Top 10 Holdings
Portfolio weighting
NEOG Neogen Corp3.14%
CMD Cantel Medical Corp2.91%
SSD Simpson Manufacturing Co Inc2.85%
OMCL Omnicell Inc2.84%
EXPO Exponent Inc2.83%
-- 2.82%
LGND Ligand Pharmaceuticals Inc2.81%
EPAY Bottomline Technologies (DE) Inc2.79%
BLKB Blackbaud Inc2.71%
MGPI MGP Ingredients Inc2.66%